BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20631026)

  • 1. Naturally-occurring mutation in the calcium-sensing receptor reveals the significance of extracellular domain loop III region for class C G-protein-coupled receptor function.
    Dong Q; Cheng Z; Chang W; Blackman BE; Conte FA; Hu J; Shoback D; Miller WL
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E245-52. PubMed ID: 20631026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
    J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.
    Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
    Pidasheva S; Canaff L; Simonds WF; Marx SJ; Hendy GN
    Hum Mol Genet; 2005 Jun; 14(12):1679-90. PubMed ID: 15879434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutation.
    Szalat A; Shahar M; Shpitzen S; Nachmias B; Munter G; Gillis D; Durst R; Mevorach D; Leitersdorf E; Meiner V; Rosen H
    Endocrine; 2015 Mar; 48(2):444-53. PubMed ID: 25091521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
    Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional analysis of novel calcium-sensing receptor gene mutation in familial hypocalciuric hypercalcemia.
    Nanjo K; Nagai S; Shimizu C; Tajima T; Kondo T; Miyoshi H; Yoshioka N; Koike T
    Endocr J; 2010; 57(9):787-92. PubMed ID: 20697181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites.
    Hannan FM; Nesbit MA; Zhang C; Cranston T; Curley AJ; Harding B; Fratter C; Rust N; Christie PT; Turner JJ; Lemos MC; Bowl MR; Bouillon R; Brain C; Bridges N; Burren C; Connell JM; Jung H; Marks E; McCredie D; Mughal Z; Rodda C; Tollefsen S; Brown EM; Yang JJ; Thakker RV
    Hum Mol Genet; 2012 Jun; 21(12):2768-78. PubMed ID: 22422767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
    Watanabe S; Fukumoto S
    Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.
    D'Souza-Li L; Yang B; Canaff L; Bai M; Hanley DA; Bastepe M; Salisbury SR; Brown EM; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1309-18. PubMed ID: 11889203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.
    Lietman SA; Tenenbaum-Rakover Y; Jap TS; Yi-Chi W; De-Ming Y; Ding C; Kussiny N; Levine MA
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4372-9. PubMed ID: 19789209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin-biased signaling.
    Gorvin CM; Babinsky VN; Malinauskas T; Nissen PH; Schou AJ; Hanyaloglu AC; Siebold C; Jones EY; Hannan FM; Thakker RV
    Sci Signal; 2018 Feb; 11(518):. PubMed ID: 29463778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced affinity of calcium sensing-receptor heterodimers and reduced mutant homodimer trafficking combine to impair function in a model of familial hypocalciuric hypercalcemia type 1.
    Wang X; Lundblad J; Smith SM
    PLoS One; 2022; 17(7):e0266993. PubMed ID: 35857775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism.
    Wystrychowski A; Pidasheva S; Canaff L; Chudek J; Kokot F; Wiecek A; Hendy GN
    J Clin Endocrinol Metab; 2005 Feb; 90(2):864-70. PubMed ID: 15572418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    D'Souza-Li L; Canaff L; Janicic N; Cole DE; Hendy GN
    Hum Mutat; 2001 Nov; 18(5):411-21. PubMed ID: 11668634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the calcium-sensing receptor in a French family with familial hypocalciuric hypercalcaemia.
    Al-Salameh A; Cetani F; Pardi E; Vulpoi C; Pierre P; de Calan L; Guyetant S; Jeunemaitre X; Lecomte P
    Eur J Endocrinol; 2011 Aug; 165(2):359-63. PubMed ID: 21566075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
    Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
    Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca
    Goolam MA; Brown AP; Edwards KT; Gregory KJ; Leach K; Conigrave AD
    J Bone Miner Res; 2022 Sep; 37(9):1787-1807. PubMed ID: 35848051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism.
    Hannan FM; Thakker RV
    Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):359-71. PubMed ID: 23856265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.